Dequilla, Jesus M.
HRN: 18-20-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/01/2023
03/14/2023
IV
2.25g
Q8
CAP HR (Antibiotic Extension)
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose